Lack of macrolide resistance in Mycoplasma genitalium infections in a cohort of pregnant women in South Africa
- 4 February 2021
- journal article
- letter
- Published by BMJ in Sexually Transmitted Infections
- Vol. 97 (8), 624-625
- https://doi.org/10.1136/sextrans-2020-054583
Abstract
No abstract availableFunding Information
- National Institute of Mental Health (R01MH116771)
- National Institute of Health and Fogarty International Center (K01TW011187)
This publication has 5 references indexed in Scilit:
- Molecular epidemiological analysis of Mycoplasma genitalium shows low prevalence of azithromycin resistance and a well-established epidemic in South AfricaSexually Transmitted Infections, 2021
- Prevalence and incidence of Mycoplasma genitalium in a cohort of HIV-infected and HIV-uninfected pregnant women in Cape Town, South AfricaSexually Transmitted Infections, 2020
- Macrolide and fluoroquinolone resistance-associated mutations in Mycoplasma genitalium in Johannesburg, South Africa, 2007–2014BMC Infectious Diseases, 2019
- Prevalence and Antimicrobial Resistance of Mycoplasma genitalium Infection Among Women Living With Human Immunodeficiency Virus in South Africa: A Prospective Cohort StudyClinical Infectious Diseases, 2019
- Prevalence and Macrolide Resistance of Mycoplasma genitalium in South African WomenSexually Transmitted Diseases, 2015